SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB : CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company developing novel ...
CERo is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Its lead product candidate is expected to enter ...
The latest price target for CERo Therapeutics Hldgs (NASDAQ:CERO) was reported by D. Boral Capital on September 5, 2025. The analyst firm set a price target for $30.00 expecting CERO to rise to within ...
Cero Therapeutics Holdings, Inc. (NASDAQ:CERO), a biotech firm specializing in biological products, is confronting the possibility of delisting from The Nasdaq Global Market due to non-compliance with ...
In the USA-Mexico rivalry, there's a scoreline that sends one fanbase into elation while irking the other. Whether it's in a high-stakes World Cup game or in a "friendly" match against El Tri, you’ll ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results